{"disease":{"id":"cancer-harboring-braf-alterations","name":"cancer harboring braf alterations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05503797","title":"A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":254,"lead_sponsor_name":"Fore Biotherapeutics","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}